Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Aims To Improve Product Risk Communication Under Strategic Plan

This article was originally published in The Gray Sheet

Executive Summary

Under a plan unveiled Sept. 30, FDA aims to increase its understanding of appropriate ways to communicate with the public about product risks and to streamline its product risk communication processes

You may also be interested in...



Risk Communication Plan On Track, FDA Staffer Reports

About a year into the implementation of FDA's risk communication plan, the agency has met most of its 2010 goals, such as publishing a risk communication research agenda, designing surveys about public understanding and improving procedures to test communications more quickly.

Risk Communication Plan On Track, FDA Staffer Reports

About a year into the implementation of FDA's risk communication plan, the agency has met most of its 2010 goals, such as publishing a risk communication research agenda, designing surveys about public understanding and improving procedures to test communications more quickly.

FDA Risk Communication Plan May Be Released Within A Month

FDA's strategic plan for ensuring the public receives accurate and balanced information about the risks and benefits of medical products could be released within a month, according to FDA Center for Drug Evaluation and Research Director Janet Woodcock

Topics

UsernamePublicRestriction

Register

LL1134882

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel